Summary
Antidepressants lead to improvement in about 70% of unselected patients with a depressive syndrome. However, many of these patients would also improve with the passage of time alone or with support and counselling. Although antidepressants are generally well tolerated, they can be expensive and are not devoid of adverse effects. Accordingly, it is worthwhile considering which patients are most likely to benefit from these drugs.
Patients who are likely to require antidepressants include those with a depression of relatively long duration, a depression of moderate or greater severity, and a depression that has melancholic or psychotic features. Patients with a history of previous depressive or manic episodes, and those showing suicidal ideation are also candidates for antidepressant treatment. Patients who show the sleep electroencephalographic (EEG) changes characteristic of depression and those with enhanced pituitary-adrenocortical activity usually require antidepressant treatment.
Once a depressed patient has responded to antidepressant treatment, further treatment for about 6 months is recommended to minimise the risk of relapse. Patients who are particularly vulnerable to recurrences may benefit from continuing antidepressant treatment beyond 6 months.
Similar content being viewed by others
References
US Department of Health and Human Services. Depression in primary care: treatment of major depression. Vol. 2, Clinical practice guideline No. 5. Washington, DC: US Government Printing Office, 1993
Brown WA, Johnson MF, Chen MG. Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res 1992; 41: 203–14
Fisher S, Greenberg RP. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis 1993; 181: 345–50
American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150: 1–26
Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46: 89–99
Styron W. Darkness visible. New York: Random House, 1990: 37
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1987
Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403–11
Khan A, Noonan C, Healey W. Is a single tricyclic antidepressant trial an active treatment for psychotic depression? Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 765–70
Peselow ED, Sanfilipo MP, Difiglia C, et al. Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 1992; 149: 1324–34
Khan A, Brown WA. Who should receive antidepressants: suggestions from placebo treatment. Psychopharmacol Bull 1991; 27: 271–4
Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093–9
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
Qutikin FM, Stewart JW, McGrath PJ, et al. Columbia atypical depression. Br J Psychiatry 1993; 163 Suppl.: 30–4
Lewy AJ. Seasonal mood disorders. In: Dunner D, editor. Current psychiatric therapy. Philadelphia: WB Saunders Co, 1993: 220–5
Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974; 125: 355–73
Ribiero SCM, Tandon R, Grunhaus L, et al. The DST as a predictor of outcome in depression; a meta-analysis. Am J Psychiatry 1993; 150: 1618–29
Thase ME, Simons AD, Reynolds CF. Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacol Bull 1993; 29: 293–301
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, W.A., Khan, A. Which Depressed Patients Should Receive Antidepressants?. CNS Drugs 1, 341–347 (1994). https://doi.org/10.2165/00023210-199401050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-199401050-00004